Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in serum ferritin level in a patient with HCV hepatitis and liver hemosiderosis by interferon-alpha

E Kawada1, S Shinonome, J Tamura

  • 1Department of Internal Medicine, Tano General Hospital, Gunma, Japan.

Journal of Medicine
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of ascorbic acid on bonding of peroxide-affected dentin and 4-META/MMA-TBB resin.

Clinical oral investigations·2006
Same author

A decade-long sour-taste sensation successfully treated with a proton-pump inhibitor.

Journal of oral rehabilitation·2005
Same author

Usefulness of FDG-PET to diagnose intravascular lymphomatosis presenting as fever of unknown origin.

American journal of hematology·2004
Same author

Effect of HEMA on bonding of Er:YAG laser-irradiated bovine dentine and 4-META/MMA-TBB resin.

Journal of oral rehabilitation·2002
Same author

The flexural properties of fiber-reinforced composite with light-polymerized polymer matrix.

The International journal of prosthodontics·2002
Same author

Intestinal absorbability of wheat allergens, subunits of a wheat alpha-amylase inhibitor, expressed by bacteria.

Bioscience, biotechnology, and biochemistry·2002

Long-term interferon-alpha therapy reduced serum ferritin in a patient with chronic hepatitis C and liver hemosiderosis. This effect is partly due to improved liver function during treatment.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Chronic hepatitis C is a significant cause of liver disease.
  • Liver hemosiderosis, characterized by iron overload, can complicate chronic liver conditions.
  • Interferon-alpha (IFN-alpha) has been used in treating chronic hepatitis C.

Observation:

  • A patient with chronic hepatitis C and liver hemosiderosis showed a notable reduction in serum ferritin levels with long-term IFN-alpha therapy.
  • Transient increase in serum ferritin was observed at the therapy's onset despite alanine aminotransferase (ALT) improvement.
  • Serum ALT levels increased upon cessation of IFN-alpha therapy, but serum ferritin did not increase correspondingly.

Findings:

  • Long-term IFN-alpha therapy effectively reduced elevated serum ferritin levels in this patient.

Related Experiment Videos

  • The primary driver for ferritin reduction appears to be the improvement in liver dysfunction.
  • IFN-alpha influences iron-related measurements, with effects partially mediated by improved hepatic status.

    • Implications:

    • IFN-alpha therapy may have a beneficial effect on iron metabolism in patients with chronic hepatitis C and hemosiderosis.
    • Monitoring serum ferritin can provide insights into treatment response and liver status during IFN-alpha therapy.
    • Further research is warranted to elucidate the precise mechanisms of IFN-alpha's impact on iron regulation in liver disease.